Andrew Radonjic – Managing Director – Venture Minerals (ASX:VMS) is dedicated to discovering and developing world-class mineral deposits to meet global demand for critical minerals vital to the green energy transition.
Copyright 2024 – Finance News Network
Source: Finance News Network
11 Mar 2021 - Rural Funds Group Limited (ASX:RFF) General Manager - Investor Relations and Marketing, James Powell, presents on the group's HY21 results.
Read More07 Jun 2021 - Chimeric Therapeutics Limited (ASX:CHM) Chief Operating Officer Jennifer Chow talks about the company's phase 1 trial results for its chlorotoxin CAR T (CLTX CAR T) cell therapy targeting glioblastoma.
Read More21 Sep 2023 - Tor McCaul - Managing Director - Comet Ridge Limited (ASX: COI) is a publicly listed Australian energy company focused on the development of natural gas resources for the strained east coast Australian market.
Read More10 May 2024 - Empire Energy Group's journey toward Beetaloo Basin production and its strategic moves, including asset sales and capital raises, shaping Australia's gas sector landscape.
Read More25 Jul 2024 - John Borshoff - Managing Director - Deep Yellow (ASX:DYL) is successfully progressing a dual-pillar growth strategy to establish a globally diversified, Tier-1 uranium company to produce 10+ Mlb pa.
Read More16 Dec 2021 - Magnetite Mines Limited (ASX:MGT) Technical Director Mark Eames discusses the global move towards low-emission steel and the implications for Australia's iron ore exports.
Read More22 Mar 2022 - Magnetite Mines Limited (ASX:MGT) Technical Director Mark Eames discusses the business case for further expansion of the Razorback Iron Ore Project in South Australia from three million tonnes per annum to seven million tonnes per annum.
Read More14 Jun 2024 - Elementos Limited (ASX:ELT) Managing Director Joe David discusses a recent agreement to acquire up to a 50% interest in an operating Spanish tin smelter.
Read More27 Mar 2024 - Empire Energy Limited (ASX:EEG) CEO Alex Underwood discusses the implications of gas shortfalls across Australia and possible sources for new supply.
Read More09 Dec 2020 - Alterity Therapeutics Limited (ASX:ATH) Chairman and CEO Geoffrey Kempler provides an update on the company's lead compound ATH434 for Multiple System Atrophy, its dual strategy in Europe and the US and its Phase 2 plans.
Read More
